Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Burtness

Showing results (71-80 of 184) with videos related to

Pageof 19
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 19, 2008
Correlates and determinants of nuclear epidermal growth factor receptor content in an oropharyngeal cancer tissue microarrayAmanda Psyrri, Brian Egleston, Paul Weinberger, et al.
Nature Reviews. Disease Primers|January 19, 2023
Author Correction: Head and neck squamous cell carcinomaDaniel E Johnson, Barbara Burtness, C René Leemans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2007
Bimodal population or pathologist artifact?David L Rimm, Jennifer M Giltnane, Christopher Moeder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2004
Sequence of radiotherapy with tamoxifen in conservatively managed breast cancer does not affect local relapse ratesPeter H Ahn, Ha Thanh Vu, Donald Lannin, et al.
Head & Neck|August 27, 2025
Evaluation of a Novel Prognostic System for Surgically Resected Oral Cavity CarcinomaAlisa Rybkin, Victor Lee, Melissa R Young, et al.
Nature Reviews. Disease Primers|November 27, 2020
Head and neck squamous cell carcinomaDaniel E Johnson, Barbara Burtness, C René Leemans, et al.
American Journal of Clinical Oncology|April 2, 2014
Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group StudyBarbara Burtness, Mark Powell, Paul Catalano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2013
Phase III randomized, placebo-controlled trial of docetaxel with or without gefitinib in recurrent or metastatic head and neck cancer: an eastern cooperative oncology group trialAthanassios Argiris, Musie Ghebremichael, Jill Gilbert, et al.
International Journal of Radiation Oncology, Biology, Physics|April 14, 2010
Use of a conventional low neck field (LNF) and intensity-modulated radiotherapy (IMRT): no clinical detriment of IMRT to an anterior LNF during the treatment of head-and neck-cancerAruna Turaka, Tianyu Li, Nicos Nicolaou, et al.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2003
Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancerLawrence Kleinberg, Jonathan P S Knisely, Richard Heitmiller, et al.
Pageof 19

Showing results (71-80 of 184) with videos related to

Sort By:
Pageof 19
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 19, 2008
Correlates and determinants of nuclear epidermal growth factor receptor content in an oropharyngeal cancer tissue microarrayAmanda Psyrri, Brian Egleston, Paul Weinberger, et al.
Nature Reviews. Disease Primers|January 19, 2023
Author Correction: Head and neck squamous cell carcinomaDaniel E Johnson, Barbara Burtness, C René Leemans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2007
Bimodal population or pathologist artifact?David L Rimm, Jennifer M Giltnane, Christopher Moeder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2004
Sequence of radiotherapy with tamoxifen in conservatively managed breast cancer does not affect local relapse ratesPeter H Ahn, Ha Thanh Vu, Donald Lannin, et al.
Head & Neck|August 27, 2025
Evaluation of a Novel Prognostic System for Surgically Resected Oral Cavity CarcinomaAlisa Rybkin, Victor Lee, Melissa R Young, et al.
Nature Reviews. Disease Primers|November 27, 2020
Head and neck squamous cell carcinomaDaniel E Johnson, Barbara Burtness, C René Leemans, et al.
American Journal of Clinical Oncology|April 2, 2014
Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group StudyBarbara Burtness, Mark Powell, Paul Catalano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2013
Phase III randomized, placebo-controlled trial of docetaxel with or without gefitinib in recurrent or metastatic head and neck cancer: an eastern cooperative oncology group trialAthanassios Argiris, Musie Ghebremichael, Jill Gilbert, et al.
International Journal of Radiation Oncology, Biology, Physics|April 14, 2010
Use of a conventional low neck field (LNF) and intensity-modulated radiotherapy (IMRT): no clinical detriment of IMRT to an anterior LNF during the treatment of head-and neck-cancerAruna Turaka, Tianyu Li, Nicos Nicolaou, et al.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2003
Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancerLawrence Kleinberg, Jonathan P S Knisely, Richard Heitmiller, et al.
Pageof 19